Compare STXS & VUZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STXS | VUZI |
|---|---|---|
| Founded | 1990 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.0M | 221.1M |
| IPO Year | 2004 | N/A |
| Metric | STXS | VUZI |
|---|---|---|
| Price | $2.35 | $3.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 392.5K | ★ 1.8M |
| Earning Date | 11-11-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,075,000.00 | $5,310,001.00 |
| Revenue This Year | $24.48 | $5.53 |
| Revenue Next Year | $29.98 | $110.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 19.62 | N/A |
| 52 Week Low | $1.54 | $1.47 |
| 52 Week High | $3.59 | $5.79 |
| Indicator | STXS | VUZI |
|---|---|---|
| Relative Strength Index (RSI) | 44.91 | 61.75 |
| Support Level | $2.31 | $2.67 |
| Resistance Level | $2.42 | $3.29 |
| Average True Range (ATR) | 0.09 | 0.20 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 56.45 | 91.57 |
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.